[Risk Management in Performing Post-Pandemic Pulmonary Function Tests]. [PDF]
Puente Maestu L +11 more
europepmc +1 more source
[Chronic Obstructive Pulmonary Disease]. [PDF]
García Castillo E +4 more
europepmc +1 more source
The Role of Indexed Left Atrial Volume in Detecting Adverse Outcomes in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study. [PDF]
Sposito MCC +11 more
europepmc +1 more source
Pulmonary function and medication effect in mild-stage subjects with Parkinson's disease. [PDF]
Oliveira RT +5 more
europepmc +1 more source
[Diaphragmatic Paralysis in Parsonage-Turner syndrome: beyond brachial neuralgia] [PDF]
Zelaya de Leon N +3 more
europepmc +1 more source
[Factors for spirometric impairment in survivors of severe coronavirus-19 disease]. [PDF]
Che-Morales JL +2 more
europepmc +1 more source
[Multidisciplinary approach of the sequelae one month after hospital discharge in patients with severe bilateral COVID-19 pneumonia, are there differences depending on the respiratory therapy used during admission to intensive care?] [PDF]
Sánchez-García AM +20 more
europepmc +1 more source
[Repeatability of spirometry's expiratory flows]. [PDF]
Santos-Martínez LE +4 more
europepmc +1 more source
Foundation: among the best lung function tests is spirometry. In post-COVID-19 patients, this allows us to evaluate the severity of the condition and follow the progression of airflow limitation, to identify obstructive, restrictive and mixed patterns ...
Paulina Marilú Puedmag Rueda +2 more
doaj
[Incidence, associated comorbidity, and risk factors for severe exacerbation of chronic obstructive pulmonary disease: A retrospective cohort study 2021-2022]. [PDF]
Montserrat-Capdevila J +3 more
europepmc +1 more source

